CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Biolexis Therapeutics
Biolexis Therapeutics logo

Biolexis Therapeutics

Biolexis Therapeutics, a biotech company, accelerates drug discovery with a unique chemical-biological approach and AI/ML platform, Moleculern™.

American Fork, UT, US🇺🇸
Founded
2021
Overview
Compare
Fundraising
Employees
Library

Biolexis Therapeutics, founded by cancer biologist Dr. David Bearss and medicinal chemist Dr. Hariprasad Vankayalapati, is a biotech company focused on accelerating drug discovery through a unique chemical-biological approach and an AI/ML platform called Moleculern™. The company specializes in developing small molecule therapeutics targeting cancers, metabolic, neurodegenerative, and autoimmune diseases. Their innovative AI-enabled process designs new chemical entities (NCEs) targeting various protein classes with unprecedented speed.

Notable figures affiliated with Biolexis Therapeutics include Dr. David Bearss and Dr. Hariprasad Vankayalapati, who together bring five decades of expertise in small molecule drug development and life science startups. The company has achieved significant milestones in its pipeline, demonstrating proof of concept for its AI-driven drug discovery process. Biolexis Therapeutics is making a substantial impact in the biotech industry by advancing the development of targeted therapies for complex diseases.

Biolexis Therapeutics - Similar Companies

Empress Therapeutics logo

Empress Therapeutics

empresstx.com

Biosim logo

Biosim

Metis Therapeutics logo

Metis Therapeutics

metistx.com

Soley Therapeutics logo

Biolexis Therapeutics - Quick Facts

Who are Biolexis Therapeutics' competitors?

Companies similar to Biolexis Therapeutics include Empress Therapeutics, Biosim, Metis Therapeutics and Soley Therapeutics.

When was Biolexis Therapeutics founded?

Biolexis Therapeutics was founded in 2021.

Where is Biolexis Therapeutics' headquarters located?

Biolexis Therapeutics' headquarters is located in American Fork, UT, US.

When was Biolexis Therapeutics' last funding round?

Biolexis Therapeutics - Classification

Ownership
  • Venture-backed
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States

Biolexis Therapeutics' most recent funding round was for $10M (USD) in November 2023.

How much disclosed funding has Biolexis Therapeutics raised?

As of Nov 29, 2023, Biolexis Therapeutics has disclosed funding of $11.5M (USD). Undisclosed round amounts are excluded.

How many employees does Biolexis Therapeutics have?

Biolexis Therapeutics has 4 employees as of Feb 5, 2024.

Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
  • Therapeutics
Tags
  • AI Operations
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC

Soley Therapeutics

DeepCure logo

DeepCure

deepcure.ai

Terray Therapeutics logo

Terray Therapeutics

terraytx.com

BioLeap logo

BioLeap

Superluminal Medicines logo

Superluminal Medicines

superluminalrx.com

Ensem Therapeutics logo

Ensem Therapeutics

ensemtx.com

OneThree Biotech logo

OneThree Biotech

onethree.bio

BioXcel Therapeutics logo

BioXcel Therapeutics

Proxima logo

Proxima

proximabio.com

Biophysical Therapeutics logo

Biophysical Therapeutics

Srnalytics logo

Srnalytics

srnalytics.com

TenSixty Biosciences logo

TenSixty Biosciences

tensixty.bio

2800
Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified